A nutrient most people associate with energy and mood turns out to matter enormously more for anyone managing epilepsy or recovering from a traumatic brain injury. It’s rarely part of the standard neurology conversation, and it should be.
Vitamin B12 gets treated, in most general wellness content, as a mild energy booster. That framing undersells what it actually does. B12 is required to build and maintain myelin, the insulating sheath around nerve fibers that lets electrical signals travel efficiently through the nervous system. For anyone whose nervous system is already under strain, whether from seizures, a traumatic brain injury, or years of anti-seizure medication, that role stops being a minor wellness detail and becomes something worth understanding properly. This is one of several conversations worth bringing to a neurology appointment — see the fuller list in Questions to Ask Your Neurologist.
Several of the most commonly prescribed anti-seizure medications measurably lower B12 and folate levels. A standard blood test can miss the deficiency entirely.
B12 and Myelin: Why This Matters Neurologically
B12 works as a cofactor for two specific enzymes in the body: methionine synthase and methylmalonyl-CoA mutase. The methionine synthase pathway is directly involved in synthesizing myelin, and when B12 is insufficient at the cellular level, that synthesis process starts to fail. The clinical consequences of longstanding B12 deficiency are well documented and specifically neurological: nerve damage, cognitive changes, and in more severe or prolonged cases, measurable demyelination visible on imaging.
For someone managing epilepsy or recovering from a brain injury, a nervous system that’s already working hard to function and repair itself has less margin to absorb an additional, quietly developing problem. That’s the practical reason this deserves more attention than the general “B12 for energy” framing usually gives it.
Which Medications Are Involved, and Why
A large study out of University Hospital Bonn, examining nearly 2,900 patients with epilepsy, found that most anti-seizure medications, including several newer ones, were associated with reduced blood levels of both folate and B12. Carbamazepine, phenytoin, oxcarbazepine, primidone, valproate, gabapentin, phenobarbital, pregabalin, and topiramate all showed this association in the data. The exceptions worth knowing: levetiracetam and benzodiazepines showed no such association in this study, which is a genuinely useful distinction if you’re trying to understand your own specific risk rather than treating every anti-seizure medication as equivalent on this front.
The mechanisms involved vary somewhat by medication, but the general pattern includes interference with folate absorption and metabolism, which in turn affects the same methylation pathways B12 depends on. Long-term phenytoin use specifically has been linked in multiple studies to progressively lower B12 and folate levels the longer treatment continues, with one study finding a statistically significant drop in patients treated more than two years compared to those treated less than one.
Why a Standard B12 Test Can Miss the Problem
A standard serum B12 test measures total B12 circulating in the blood, most of which is bound to a protein called haptocorrin and isn’t actually available for cells to use. That means a serum B12 result can look normal, or even comfortably within range, while the biologically active portion your nervous system depends on is genuinely insufficient. This gap between the total number and the functional reality is exactly why relying on serum B12 alone can leave a real, developing deficiency undetected, particularly in someone whose neurological margin is already reduced.
It’s worth being honest about the limits of the more specialized tests too, rather than treating them as automatically superior. A large 2020 study comparing four different B12 markers found that for most men and for women under 50, the more sophisticated tests weren’t meaningfully better than standard serum B12 at catching deficiency. Where they clearly earned their place was in women 50 and older, where a more sensitive marker outperformed serum B12 specifically. The honest takeaway: functional testing is a genuinely useful tool in the right situation, not an automatic upgrade for everyone in every case.
The Tests That Actually Catch It
Three markers, used together, give a fuller picture than serum B12 alone.
Methylmalonic acid (MMA) is considered a functional marker of B12 status. When B12 is insufficient at the cellular level, MMA tends to rise before serum B12 itself drops below the standard cutoff, which is exactly the scenario that makes it useful for catching deficiency early. Elevated MMA isn’t just a marker, either; it’s directly implicated in disrupting normal lipid metabolism and mitochondrial energy production, contributing to the same myelin instability the deficiency is causing in the first place.
Homocysteine rises when either B12 or folate is insufficient, since both nutrients are required for the same methylation cycle. An elevated result doesn’t tell you which of the two is the problem on its own, but paired with the other markers, it adds useful confirmation.
Holotranscobalamin (active B12, or holoTC) measures the specific fraction of B12 that’s actually bound to the transport protein your cells can use, rather than total circulating B12. It’s considered the earliest marker to shift when B12 stores start to deplete, which is why it’s often described as catching the problem before it becomes a fuller deficiency.
Used together, a lowered holoTC alongside elevated MMA and homocysteine indicates a metabolically real B12 deficiency, sometimes before any symptoms have become noticeable at all.
Getting the Right Tests From Your Doctor
Most primary care and neurology visits default to a standard serum B12 test, if B12 comes up at all. If you’re on one of the medications associated with reduced B12 or folate, a direct, specific request tends to work better than a general mention of fatigue or brain fog: ask specifically for MMA and homocysteine alongside serum B12, and ask whether holotranscobalamin is available through your lab, particularly if you’re a woman over 50, where the evidence for its added value is strongest.
Framing it around the medication connection tends to land better than framing it around a vague symptom: “I’m on a medication known to lower B12 and folate levels, and I’d like to check my functional status with MMA and homocysteine, not just serum B12” gives a provider something concrete and specific to act on.
Shop This Category
For the crystalline, active forms of B12 and other daily essentials discussed above, my Amazon storefront reflects what I actually use.
Browse My Full Amazon Storefront →
FAQ
Does every anti-seizure medication lower B12?
No. The largest study on this found levetiracetam and benzodiazepines showed no association with reduced B12 or folate, while most other commonly used anti-seizure medications did show a measurable association. Which medication you’re on genuinely changes your individual risk here.
Should I just start taking a B12 supplement without testing first?
Testing first gives you and your provider an actual baseline to work from, and it matters for dosing and form. It’s a reasonable conversation to have with a neurologist or primary care provider rather than a decision to make blind.
If my serum B12 came back normal, does that rule out a problem?
Not necessarily. A normal serum B12 result doesn’t rule out a functional deficiency, particularly if you’re on a medication associated with reduced levels. That’s exactly the gap MMA, homocysteine, and holotranscobalamin are designed to catch.
Is this only relevant for people with anemia symptoms?
No. Neurological symptoms from B12 deficiency, including nerve changes and cognitive effects, can appear well before anemia shows up on a basic blood panel. Waiting for anemia to prompt testing misses the window where catching this early matters most.
B12 isn’t a wellness add-on for anyone managing a taxed nervous system. It’s a specific, testable, medication-related factor worth asking about directly.
This is one piece of the fuller picture worth discussing with your neurologist alongside bone density, hormonal health, and SUDEP risk. I’ve written a full breakdown of all four in Questions to Ask Your Neurologist, and the medication-specific mechanisms behind bone and hormonal effects in What Long-Term Anti-Seizure Medications Do to Your Bones and Hormones.
